Implementing AI to help track, analyze, simulate, and predict population-level disease outcomes

Global health challenges cannot be solved without better data. Airfinity tracks, predicts and simulates population level disease outcomes in real time to inform decisions that can increase the global life span.

Multiple industries have relied on forecasting for decades. We believe it’s time for the pharmaceutical industry to catch up by providing tailored intelligence solutions built on proprietary technology, data and expert analysts.

Airfinity uses a unique quantitative approach that combines advanced meta science and statistics, large language models, epidemiology, and dynamic machine learning solutions to understand true disease prevalence and underlying outcome drivers as they evolve. 

By building AI and large-scale simulation model forecasts focusing on the predictive indicators that could significantly impact disease burden, we can help provide a more nuanced and holistic view of the changing landscape, including any ‘blind spots’ your organization or the industry might have. 

Airfinity is continuously refining its models, diversifying its data sets, and expanding its disease coverage to ensure our team produces the highest quality intelligence and predictions. 

Schedule a free session with our quant analysts to better understand how Airfinity deploys these different technologies within your disease or therapy area of focus. 

Get in touch to find out more

Fill in the below form and a member of the team will be in touch.

Get in touch to find out more

Fill in the below form and a member of the team will be in touch.

Analysis & Insights

Is the world ready for a bird flu pandemic? Airfinity assesses global vaccine stockpiles and preparedness
Is the world ready for a bird flu pandemic? Airfinity assesses global vaccine stockpiles and preparedness

Read More →


More from Airfinity

A New Era in Immunisation: Forecasting the Future of Combination Respiratory Vaccines

Airfinity Wins FT Tech Champions 2023

Airfinity Wins Bloomberg Top 25 UK Startups to Watch

What other conditions could weight-loss drugs treat?

Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels

The West should be on a war footing for the next pandemic

View All →

In the News

Trump administration cancels multi-million dollar bird flu vaccine contract with Moderna

The Telegraph | May 29, 2025

EU shores up pandemic defences with 478m flu vaccine deal

The Telegraph | May 7, 2025

The future of weight loss drugs: gummies, tablets and melt-in-the-mouth strips

The i Paper | Mar 28, 2025

Value of investment on NCDs: Impact on health outcomes in low- and middle-income countries

IFPMA | Mar 11, 2025

View All →